Vay Luy Jetzer-Chung

Vay Luy Jetzer-Chung (鍾慧莉) currently serves as the Director Marketing Pharma & Nutrition and is a member of the Executive Board at Fresenius Kabi since January 2024, responsible for the marketing of pharmaceuticals and clinical nutrition. Prior to this role, Vay held various positions at Eli Lilly and Company from 2018 to December 2023, including Senior Director and Brand Director in Rheumatology, with a significant focus on marketing and P&L responsibility. Previous experience includes roles at Novartis, Roche, and various Swiss Federal Departments, emphasizing trade diplomacy and economic affairs. Vay holds multiple degrees, including an MBA from INSEAD and a Master of Science from HEC Lausanne, along with certifications in business performance coaching and global health diplomacy.